Aducanumab: The first targeted Alzheimer's therapy
Author:
Affiliation:
1. Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.
2. Department of Pharmacy, Qingdao Municipal Hospital, Qingdao, Shandong, China.
Publisher
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine
Link
https://www.jstage.jst.go.jp/article/ddt/15/3/15_2021.01061/_pdf
Reference23 articles.
1. 1. Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM. Alzheimer's disease. Lancet. 2016; 388:505-517.
2. 2. 2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021; 17:327-406.
3. 3. Long JM, Holtzman DM. Alzheimer disease: An update on pathobiology and treatment strategies. Cell. 2019; 179:312-339.
4. 4. FDA's Decision to Approve New Treatment for Alzheimer's Disease. https://wwwfdagov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease. (accessed June 7, 2021).
5. 5. Kent SA, Spires-Jones TL, Durrant CS. The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics. Acta Neuropathol. 2020; 140:417-447.
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapeutic effects of a new bithiophene against aluminum -induced Alzheimer’s disease in a rat model: Pathological and ultrastructural approach;Tissue and Cell;2024-10
2. Lacticaseibacillus rhamnosus HA-114 and Bacillus subtilis R0179 Prolong Lifespan and Mitigate Amyloid-β Toxicity in C. elegans via Distinct Mechanisms;Journal of Alzheimer's Disease;2024-08-27
3. Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-07-30
4. Application Study of Enzyme Inhibitors and Their Conformational Optimization in The Treatment of Alzheimer's Disease;PROG BIOCHEM BIOPHYS;2024
5. Molecular hybridization: a powerful tool for multitarget drug discovery;Expert Opinion on Drug Discovery;2024-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3